News and blog posts
17
May 2022
On April 21, 2022, NHS England and NHS Improvement updated the 2021/22 National Genomic Test Directory (version 3), which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Forty-two new codes (test-indication combinations) were introduced in the cancer field, and fourteen for rare and inherited diseases.
Read more
16
May 2022
The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in April 2022. Thirty recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, orthopedic, neurovascular, and neuromodulation and other devices, as well as medical aids.
Read more
13
May 2022
In April 2022, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 0183 and 0080 with changes to be implemented no later than June 14, 2022. Eleven new procedure codes and nine new diagnostic codes were introduced.
Read more
12
May 2022
This free webinar provides an overview of the comprehensive process to establish pathway-specific and fact-based evidence requirements for medical technologies to meet the requirements of reimbursement, funding and HTA authorities.
Read more
12
May 2022
MoveUP is the first digital health app that has reached the level 3 level on the Mhealth validation pyramid. This means that the app is now reimbursed in Belgium.
Read more
11
May 2022
On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, which recommended the transfer to standard care for two completed projects. The projects relate to the management of rare diseases and the strengthening of the regional healthcare structures and processes.
Read more
10
May 2022
A new test called Genedrive System to detect babies at risk of gentamycin-related deafness was developed at the University of Manchester, funded by the National Institute for Health and Care Research (NIHR). On April 02, 2022, NHS England and NHS Improvement announced that Genedrive is now fully CE certified to be used in a clinical setting. The test is expected to be implemented in routine care in all NHS Manchester Foundation Trust hospitals within several weeks.
Read more
09
May 2022
On April 1, 2022, the entity managing the DRG system in Switzerland, SwissDRG, announced that they will be accepting applications for changes in the DRG system from June 6, 2022, until July 17, 2022. The results of the DRG applications made in 2022 will be reflected in the 2024 version of SwissDRG.
Read more
06
May 2022
In Q1 of 2022, Health Technology Wales (HTW) published one MedTech-related guidance on transcranial magnetic stimulation in depression treatment. A total of eleven Topic Exploration Reports (TERs) were released in Q1. Based on the TERs conclusions, HTW's Assessment Group decided to proceed with developing an Evidence Appraisal Report (EAR) and Guidance on one topic only - radiofrequency renal denervation for the treatment of resistant hypertension.
Read more
05
May 2022
In March and April 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty-three health apps are now available at the DiGA Directory.
Read more
04
May 2022
On March 31, 2022, the updated intra-DRG list was published. It includes the modifications of registration conditions for several devices included in the list. No new devices were added to the list.
Read more
03
May 2022
On April 12, 2022, NHS England and NHS Improvement (NHSE/I) published 2022/23 priorities and operational planning guidance, including elective recovery planning supporting guidance, capital guidance for 2022-25, and revenue finance and contracting guidance. The 2022/23 priorities and operational planning guidance set out NHSE/I priorities for the year ahead and reconfirms the ongoing need to restore services, meet new care demands, and reduce the care backlogs that are a direct consequence of the pandemic.
Read more